Roth MKM analyst Richard Baldry initiated coverage of Forian with a Buy rating and $5 price target. The firm, which calls Forian’s healthcare data-centric platform “a uniquely valuable Cloud Data Services franchise,” believes its recurring revenue model offers investors an attractive combination of organic growth and scaling profitability.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FORA: